The International Society for Pharmaceutical Engineering (ISPE) – the world’s largest, not-for-profit association dedicated to the pharmaceutical industry, and publisher of the GAMP® good practice guides and Pharmaceutical Engineering magazine – recently selected an article submitted by Innovatum, Inc., a leading provider of enterprise compliance software and services to the Life Sciences, for publication in the May/June issue of Pharmaceutical Engineering focused on “Green Pharma.”
The article, titled “Labeling Pharma ‘Green,’” provides a thorough summary of the potential for an Electronic/Enterprise Label Management System (ELMS) to reduce paper & label stock consumption; improve operational & manufacturing efficiencies; accelerate time-to-market, comply with FDA & international labeling regulations (e.g. 21 CFR Part 11, cGMP etc); and deliver a rapid return on investment (ROI) to pharmaceutical manufacturers. It also includes tools and tips to help pharmaceutical manufacturers analyze and quantify the costs associated with their existing labeling system(s) and SOPs in order to determine if an ELMS warrants further consideration.
Innovatum Vice President of Operations and long-time ISPE member, Dana Buker, acted as lead author on the article; drawing on his 20+ years of experience in the pharmaceutical industry. “Innovatum is honored to share the value of our experience with ISPE members in Pharmaceutical Engineering,” said Buker. The May/June issue is scheduled for publication on May 20th, 2011, but an advance copy of “Labeling Pharma ‘Green’” is available here.
